The goal of this clinical trial is to Clinical and Radiographic Evaluation of Hyaluronic Acid (Gengigel Teething) Versus Mineral Trioxide Aggregate( Angelus) as Pulpotomy Agent in Vital Primary Molars.
The main question it aims to answer is:
Is there a difference in the clinical or radiographic success when using Hyaluronic acid (Gengigel Teething, Ricerfarma , Italy) versus mineral trioxide aggregate (Angelus, Londrina ,Brazil) in pulpotomy of carious primary molars in children?
Restorable mandibular primary molars.
History of reversible pulpitis.
Absence of periapical or inter-radicular radiolucencies.
Absence of widening of periodontal ligaments (PDL) space.
With systemic disorders.
Physical or mental disabilities.
Unable to attend follow- up visits.
Refusal of Participation.